Nothing Special   »   [go: up one dir, main page]

MA41558A - Compositions d'allergènes mélangés et leurs procédés d'utilisation - Google Patents

Compositions d'allergènes mélangés et leurs procédés d'utilisation

Info

Publication number
MA41558A
MA41558A MA041558A MA41558A MA41558A MA 41558 A MA41558 A MA 41558A MA 041558 A MA041558 A MA 041558A MA 41558 A MA41558 A MA 41558A MA 41558 A MA41558 A MA 41558A
Authority
MA
Morocco
Prior art keywords
processes
mixed allergen
allergen compositions
compositions
mixed
Prior art date
Application number
MA041558A
Other languages
English (en)
Other versions
MA41558B1 (fr
Inventor
Kari C Nadeau
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56689334&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA41558(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of MA41558A publication Critical patent/MA41558A/fr
Publication of MA41558B1 publication Critical patent/MA41558B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA41558A 2015-02-20 2016-02-19 Compositions d'allergènes mélangés et leurs procédés d'utilisation MA41558B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562119014P 2015-02-20 2015-02-20
PCT/US2016/018731 WO2016134291A2 (fr) 2015-02-20 2016-02-19 Compositions d'allergènes mélangés et leurs procédés d'utilisation

Publications (2)

Publication Number Publication Date
MA41558A true MA41558A (fr) 2017-12-26
MA41558B1 MA41558B1 (fr) 2023-02-28

Family

ID=56689334

Family Applications (1)

Application Number Title Priority Date Filing Date
MA41558A MA41558B1 (fr) 2015-02-20 2016-02-19 Compositions d'allergènes mélangés et leurs procédés d'utilisation

Country Status (22)

Country Link
US (4) US10064936B2 (fr)
EP (2) EP4186521A1 (fr)
JP (3) JP6859261B2 (fr)
KR (2) KR20170117562A (fr)
CN (2) CN114129720A (fr)
AU (2) AU2016219793C1 (fr)
CA (1) CA2977127A1 (fr)
DK (1) DK3258962T3 (fr)
ES (1) ES2937287T3 (fr)
FI (1) FI3258962T3 (fr)
HK (1) HK1247854A1 (fr)
HU (1) HUE061576T2 (fr)
IL (1) IL253976B2 (fr)
LT (1) LT3258962T (fr)
MA (1) MA41558B1 (fr)
MX (2) MX2017010697A (fr)
PL (1) PL3258962T3 (fr)
PT (1) PT3258962T (fr)
RS (1) RS63941B1 (fr)
SG (2) SG11201706734SA (fr)
SI (1) SI3258962T1 (fr)
WO (1) WO2016134291A2 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL253976B2 (en) 2015-02-20 2024-09-01 Univ Leland Stanford Junior Preparations containing a mixture of allergens and methods of using them
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) * 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US20160263212A1 (en) * 2015-02-23 2016-09-15 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens
US10856567B2 (en) 2016-07-22 2020-12-08 Kari Brown Baby food products containing allergenic proteins and methods of delivering same
NZ753163A (en) * 2016-11-21 2023-05-26 Nestle Sa Liquid allergen compositions and methods for making the same
US10656145B2 (en) 2016-12-09 2020-05-19 General Mills, Inc. Detection of allergens using surface-enhanced raman scattering
JP2020514306A (ja) * 2017-01-13 2020-05-21 アイミューン セラピューティクス，インコーポレイテッド 経口免疫療法用のナッツ粉および製剤の製造方法
FR3062797A1 (fr) * 2017-02-10 2018-08-17 Centre Hospitalier Et Universitaire De Clermont-Ferrand Gelule a liberation gastro-intestinale destinee a etre utilisee dans une methode permettant de desensibiliser et/ou d'induire une tolerance chez un sujet allergique a l'arachide
US20180360951A1 (en) * 2017-06-20 2018-12-20 Evros Vassiliou Method, composition & apparatus for the treatment of type i allergic hypersensitivities by immune desensitization through slit immunotherapy with unadulterated allergen, vitamin a and vitamin d
IL272033B2 (en) 2017-07-18 2023-09-01 Before Brands Inc Methods for the preparation of mixed allergen preparations
US11173113B2 (en) 2017-12-06 2021-11-16 Prollergy Corporation Composition and method for reducing allergic response
EP3836801A4 (fr) * 2018-08-16 2022-05-18 Société des Produits Nestlé S.A. Immunothérapie orale de désensibilisation à l'arachide avec dose d'entretien
EP3886899A1 (fr) * 2018-11-30 2021-10-06 Alladapt Immunotherapeutics, Inc. Procédés de production de compositions d'allergènes mixtes
JP2022514642A (ja) * 2018-12-21 2022-02-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 乳児用飲用組成物
KR20210130147A (ko) 2019-01-23 2021-10-29 비포어 브랜즈, 인크. 혼합 알레르겐 조성물의 제조 방법
US20200236982A1 (en) * 2019-01-28 2020-07-30 Lil Mixins, Llc Tree nut powder formulation
US11154082B2 (en) 2019-06-13 2021-10-26 Lil Mixins, Llc Egg product for infants and babies and method of making same
US11324247B2 (en) 2019-06-13 2022-05-10 Lil Mixins, Llc Food products for infants and babies and method of making same
WO2022185284A1 (fr) * 2021-03-05 2022-09-09 Société des Produits Nestlé S.A. Procédés de fabrication et d'évaluation de compositions de noix allergènes
US11154081B1 (en) 2021-03-16 2021-10-26 Lil Mixins, Llc Well cooked egg powder
US11439173B1 (en) 2021-09-22 2022-09-13 Lil Mixins, Llc Low allergenicity well cooked food powder

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031199A (en) 1972-12-11 1977-06-21 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
GB9323483D0 (en) 1993-11-13 1994-01-05 Cerestar Holding Bv Edible composition and a process for its preparation
AU2065801A (en) 1999-12-06 2001-06-12 Panacea Pharmaceuticals, Llc Passive desensitization
US6716471B2 (en) 2000-05-12 2004-04-06 Sigmund Kramer Peanut powder compositions and methods of making same
FR2822709B1 (fr) 2001-03-30 2007-01-19 Antialis Composition pharmaceutique anti-allergique comprenant au moins un allergene et au moins un compose antihistaminique
DE602004032025D1 (de) 2003-06-23 2011-05-12 Biotech Tools Sa Epitop-zusammensetzung zur enterischen verabreichung hergestellt durch hydrolyse von antigenen strukturen mit chymotrypsin
US7595081B1 (en) 2003-10-17 2009-09-29 Bellar Willis F Non-flour containing baked and related food compositions
WO2005077410A1 (fr) * 2004-02-06 2005-08-25 Greer Laboratories, Inc. Procedes et compositions pour le dosage d'allergenes
EP1993376A1 (fr) * 2006-02-27 2008-11-26 The Iams Company Composition alimentaire pour animaux comprenant de la coquille de noix
EP1872792A1 (fr) 2006-06-29 2008-01-02 Biotech Tools S.A. Méthode pour la production d'un allergène hydrolysé
CN101646418B (zh) * 2006-10-12 2013-07-17 昆士兰大学 调节免疫应答的组合物和方法
US8709413B2 (en) 2006-12-13 2014-04-29 Michael R. Simon Treatment of celiac disease with IgA
US20100278880A1 (en) 2008-01-02 2010-11-04 Biotech Tools S.A. Pharmaceutical formulation for allergen preparation
SI2244734T1 (sl) 2008-02-01 2016-11-30 Murdoch Childrens Research Institute Postopek induciranja tolerance na alergen
EP2140880B1 (fr) 2008-07-04 2012-11-14 HAL Allergy Holding B.V. Modification d'allergènes
US8802056B2 (en) 2008-07-17 2014-08-12 John Shea Method for testing and treating delayed food allergies
JP5805363B2 (ja) 2009-06-26 2015-11-04 和興フィルタテクノロジー株式会社 可溶性凝集体、免疫寛容誘導剤及びその製造方法
CN102695427B (zh) * 2009-08-18 2016-04-13 雀巢产品技术援助有限公司 包含乳球菌属菌株并且特别是在婴儿和儿童中减少过敏症状的营养组合物
BR112012005117A2 (pt) * 2009-09-07 2016-05-03 Dbv Tech método de tratamento de esofagite eosinofílica
CN102048077A (zh) * 2009-10-30 2011-05-11 梁振 一种方便营养果丁豆花
ES2904800T3 (es) 2010-04-30 2022-04-06 Allovate Llc Tira oral para desensibilización alérgica a través de la superficie de la mucosa vestibular
EP2563390A4 (fr) * 2010-04-30 2014-05-14 Allovate Llc Procédes et articles de prévention ou de réduction du risque de développement d'un système immunitaire hyperallergénique
GB201009368D0 (en) 2010-06-04 2010-07-21 Sana Pharma As Dietary formulations
EP2627355B1 (fr) 2010-10-15 2015-08-26 ALK-Abelló A/S Suppression d'une réponse immunitaire d'hypersensibilité à l'aide d'un antigène non apparenté issu d'une matière source d'allergène
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
CN102986802A (zh) 2012-12-11 2013-03-27 崔杰 一种花生核桃咸饼的制作方法
US9492535B2 (en) 2013-03-14 2016-11-15 Aimmune Therapeutics, Inc. Peanut formulations and uses thereof
CA2903229A1 (fr) 2013-03-14 2014-10-02 Aimmune Therapeutics, Inc. Fabrication de formulations de cacahouete pour la desensibilisation orale
BR112015024040A2 (pt) 2013-03-19 2017-07-18 Biotech Tools Sa preparação alergênica
WO2014195803A2 (fr) 2013-06-06 2014-12-11 Anergis S.A. Peptides contigus se chevauchant pour le traitement d'une allergie aux acariens de la poussière
KR102385900B1 (ko) * 2013-09-19 2022-04-11 알로베이트, 엘엘씨 구강점막으로 알레르겐을 전달하기 위한 치약
EP2952200A1 (fr) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergène pour le traitement prophylactique d'une allergie
KR102541110B1 (ko) 2014-08-25 2023-06-08 에이뮨 테라퓨틱스, 인코퍼레이티드 난 단백질 제형 및 이의 제조 방법
CN104273238A (zh) * 2014-09-27 2015-01-14 合肥市凤落河豆制食品有限公司 一种芝麻酱干及其制备方法
US10166286B2 (en) * 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) * 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) * 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
IL253976B2 (en) * 2015-02-20 2024-09-01 Univ Leland Stanford Junior Preparations containing a mixture of allergens and methods of using them
US20160263212A1 (en) 2015-02-23 2016-09-15 Antera Therapeutics Inc. Compositions and methods for tolerizing the immune system to allergens

Also Published As

Publication number Publication date
KR20170117562A (ko) 2017-10-23
EP3258962A2 (fr) 2017-12-27
JP6859261B2 (ja) 2021-04-14
AU2022201699A1 (en) 2022-04-07
SI3258962T1 (sl) 2023-07-31
JP2021046445A (ja) 2021-03-25
MX2017010697A (es) 2017-11-17
PL3258962T3 (pl) 2023-04-24
AU2016219793B2 (en) 2021-12-16
HK1247854A1 (zh) 2018-10-05
IL253976A0 (en) 2017-10-31
US20170056494A1 (en) 2017-03-02
LT3258962T (lt) 2023-02-27
US20220133882A1 (en) 2022-05-05
HUE061576T2 (hu) 2023-07-28
EP3258962A4 (fr) 2018-07-11
JP2022125346A (ja) 2022-08-26
CN107405394A (zh) 2017-11-28
BR112017017894A2 (pt) 2018-04-10
IL253976B1 (en) 2024-05-01
US9731003B2 (en) 2017-08-15
US10064936B2 (en) 2018-09-04
FI3258962T3 (fi) 2023-04-12
CN107405394B (zh) 2021-12-14
WO2016134291A2 (fr) 2016-08-25
AU2016219793A1 (en) 2017-08-31
EP4186521A1 (fr) 2023-05-31
EP3258962B1 (fr) 2022-11-02
JP7509829B2 (ja) 2024-07-02
US20190038741A1 (en) 2019-02-07
AU2016219793C1 (en) 2022-03-17
MX2022008663A (es) 2022-08-10
IL253976B2 (en) 2024-09-01
CN114129720A (zh) 2022-03-04
US20160243217A1 (en) 2016-08-25
JP2018505907A (ja) 2018-03-01
CA2977127A1 (fr) 2016-08-25
ES2937287T3 (es) 2023-03-27
KR20240148968A (ko) 2024-10-11
RS63941B1 (sr) 2023-02-28
SG11201706734SA (en) 2017-09-28
WO2016134291A3 (fr) 2016-10-13
PT3258962T (pt) 2023-02-16
MA41558B1 (fr) 2023-02-28
DK3258962T3 (da) 2023-02-06
SG10201909093XA (en) 2019-11-28

Similar Documents

Publication Publication Date Title
MA41558A (fr) Compositions d'allergènes mélangés et leurs procédés d'utilisation
MA46529A (fr) Anticorps anti-lag-3 et leurs procédés d'utilisation
MA43389A (fr) Anticorps anti-ox40 et leurs procédés d'utilisation
MA41999A (fr) Compositions d'acide obéticholique et procédés d'utilisation
MA45779A (fr) Polypeptides immunomdulateurs et compositions et procédés associés
MA50949A (fr) Anticorps anti-ctla-4 et leurs procédés d'utilisation
MA43380A (fr) Récepteurs chimériques modifiés et compositions et procédés associés
MA46427A (fr) Compositions d'oligonucléotides et procédés associés
MA53355A (fr) Anticorps anti-ctla-4 et leurs procédés d'utilisation
MA44524A (fr) Néoantigènes et leurs procédés d'utilisation
MA43827A (fr) Composés di-nucléotides cycliques et leurs procédés d'utilisation
MA42447A (fr) Anticorps anti-pd-1, anticorps anti-pd-1 activables, et leurs procédés d'utilisation
MA42971A (fr) Anticorps anti-pdl1, anticorps anti-pld1 activables, et leurs procédés d'utilisation
MA55097A (fr) Oxystérols et leurs procédés d'utilisation
MA40069A (fr) Molécules de liaison trispécifiques et leurs procédés d'utilisation
MA47849A (fr) Anticorps anti-gitr et leurs procédés d'utilisation
MA42043A (fr) Anticorps anti-ox40 et procédés d'utilisation de ceux-ci
MA46566A (fr) Oxystérols et leurs procédés d'utilisation
MA43365A (fr) Anticorps anti-dr5 et procédés d'utilisation de ceux-ci
MA42409A (fr) Oxystérols et leurs procédés d'utilisation
MA54851A (fr) Oxystérols et leurs procédés d'utilisation
MA46565A (fr) Oxystérols et leurs procédés d'utilisation
MA45270A (fr) Compositions d'oligonucléotides et procédés associés
MA41296A (fr) Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
MA39915A (fr) Composés de pladiénolide pyridine et leurs procédés d'utilisation